Form 4: Opaleye Management Inc. Reduces Stake in Protara Therapeutics
SEC Form 4 Filing
Opaleye Management Inc. reports selling shares of Protara Therapeutics (TARA) on September 11 and 12, 2024, reducing its beneficial ownership.
Summary
- Opaleye Management Inc., a 10% owner of Protara Therapeutics, Inc. (TARA), filed a Form 4 detailing changes in beneficial ownership.
- On September 11, 2024, Opaleye Management Inc. sold 31,000 shares of common stock at a weighted average price of $1.7141, with prices ranging from $1.70 to $1.74.
- An additional 1,600 shares were sold on the same day at $1.7141 through a managed account.
- On September 12, 2024, Opaleye Management Inc. sold 119,801 shares at a weighted average price of $1.7089, with prices ranging from $1.70 to $1.75.
- Another 6,500 shares were sold on September 12, 2024, through a managed account at $1.7089.
- Following these transactions, Opaleye, L.P. beneficially owns 1,944,134 shares, and a managed account beneficially owns 45,000 shares.
- The sales were executed pursuant to Rule 10b5-1(c).
Sentiment
Score: 4
Explanation: The sentiment is slightly negative due to the reduction in stake by a major shareholder, Opaleye Management Inc. While the sales were conducted under a pre-arranged trading plan, the market may still interpret this as a lack of confidence in the company's future prospects.
Negatives
- Opaleye Management Inc., a significant shareholder, reduced its stake in Protara Therapeutics, which could be perceived negatively by the market.
Risks
- Continued selling pressure from Opaleye Management Inc. could further depress the stock price.
- The reasons behind Opaleye's decision to sell shares are not disclosed, creating uncertainty for investors.
Industry Context
Form 4 filings are routine disclosures for significant shareholders and company insiders, providing transparency into their trading activities. These filings are closely watched by investors for signals about the company's prospects.
Stakeholder Impact
- Shareholders may react negatively to the news of Opaleye Management Inc.'s reduced stake, potentially leading to a decrease in stock price.
Key Dates
| Date | Description |
|---|---|
| 09/11/2024 | Opaleye Management Inc. sold 31,000 shares of TARA at a weighted average price of $1.7141 and 1,600 shares through a managed account at $1.7141. |
| 09/12/2024 | Opaleye Management Inc. sold 119,801 shares of TARA at a weighted average price of $1.7089 and 6,500 shares through a managed account at $1.7089. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.